Ge Health Care Technologies Inc. GEHC
We take great care to ensure that the data presented and summarized in this overview for GE HealthCare Technologies Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GEHC
Top Purchases
Top Sells
About GEHC
Insider Transactions at GEHC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 03
2025
|
Thomas J. Westrick CEO, Patient Care Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
3,181
+14.67%
|
-
|
Mar 03
2025
|
George A. Newcomb Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,156
+13.05%
|
-
|
Mar 03
2025
|
Philip Rackliffe CEO, AVS |
BUY
Grant, award, or other acquisition
|
Direct |
4,916
+21.96%
|
-
|
Mar 03
2025
|
Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. |
BUY
Grant, award, or other acquisition
|
Direct |
5,060
+13.78%
|
-
|
Mar 03
2025
|
Kevin Michael O'Neill CEO, PDx |
BUY
Grant, award, or other acquisition
|
Direct |
4,626
+16.76%
|
-
|
Mar 03
2025
|
Frank R Jimenez GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
10,121
+12.39%
|
-
|
Mar 03
2025
|
Roland Rott CEO, Imaging |
BUY
Grant, award, or other acquisition
|
Direct |
7,952
+20.82%
|
-
|
Mar 03
2025
|
James Saccaro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,278
+13.62%
|
-
|
Mar 03
2025
|
Adam Y Holton Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,337
+20.11%
|
-
|
Mar 03
2025
|
Peter J Arduini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
41,931
+18.96%
|
-
|
Mar 03
2025
|
Taha Kass Hout Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,567
+14.49%
|
-
|
Mar 01
2025
|
Thomas J. Westrick CEO, Patient Care Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,822
-5.46%
|
$158,514
$87.35 P/Share
|
Mar 01
2025
|
George A. Newcomb Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
913
-6.31%
|
$79,431
$87.35 P/Share
|
Mar 01
2025
|
Kevin Michael O'Neill CEO, PDx |
SELL
Payment of exercise price or tax liability
|
Direct |
3,661
-8.69%
|
$318,507
$87.35 P/Share
|
Mar 01
2025
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,457
-6.14%
|
$126,759
$87.35 P/Share
|
Mar 01
2025
|
Peter J Arduini President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
34,325
-10.23%
|
$2,986,275
$87.35 P/Share
|
Mar 01
2025
|
Frank R Jimenez GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
11,667
-8.32%
|
$1,015,029
$87.35 P/Share
|
Feb 18
2025
|
George A. Newcomb Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,000
-21.14%
|
$184,000
$92.54 P/Share
|
Feb 06
2025
|
Peter J Arduini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
67,487
+28.22%
|
-
|
Feb 02
2025
|
Taha Kass Hout Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,122
-12.53%
|
$714,736
$88.3 P/Share
|
Last 12 Months Summary
Buy / Acquisition
320K
Shares
From
23
Insiders
Grant, award, or other acquisition | 218K shares |
---|---|
Open market or private purchase | 1.32K shares |
Exercise of conversion of derivative security | 100K shares |
Sell / Disposition
527K
Shares
From
18
Insiders
Payment of exercise price or tax liability | 408K shares |
---|---|
Open market or private sale | 119K shares |